Top Markets
#1 CyberDEX CyberDEX +391.95%
#2 OVERTAKE OVERTAKE +58.99%
#3 Clearpool Clearpool +25.94%
#4 Playnance Playnance +23.93%
#5 deBridge deBridge +22.97%
#6 B3 (Base) B3 (Base) +20.83%
#7 Nillion Nillion +19.56%
#8 AUKI AUKI +19.09%
#9 Codatta Codatta +17.25%
#10 龙虾 (Lobster) 龙虾 (Lobster) +17.03%
Coin of the day
CyberDEX CyberDEX
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Nuformix plc Nuformix plc

Nuformix plc

NFX
Classement en actions #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Prix de l'action
$0.00185055
Capitalisation boursière
$48.29K
Changement (1 jour)
-3.55%
Changement (1 an)
30.31%
Pays
GB
Échange Nuformix plc (NFX)

Catégorie

Healthcare
Nombre d'actions en circulation pour Nuformix plc (NFX)
Nombre d'actions en circulation au March 2026: 2.12B
Selon les derniers rapports financiers et le cours de l'action de Nuformix plc, le nombre actuel d'actions en circulation est de 2.12B. À la fin de September 2024, l'entreprise avait 787.01M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Nuformix plc (NFX) de 2014 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 2.12B 27.71%
2025 1.66B 111.05%
2024 787.01M 9.39%
2023 719.46M 20.22%
2022 598.45M 3.07%
2021 580.63M 21.71%
2020 477.06M 3.54%
2019 460.75M 23.34%
2018 373.55M 290.13%
2017 95.75M 59.34%
2016 60.09M 0.00%
2014 0.00 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -88.03%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -81.33%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -77.42%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -97.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH